SiteOne Therapeutics

About:

SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics.

Website: https://www.siteonetherapeutics.com/

Top Investors: Mission BioCapital, Amgen, National Institute on Drug Abuse (NIDA), NEXT Frontier Capital, 2M Companies

Description:

SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics. They develop products safely, effectively, and efficiently treat acute and chronic pain without the limitations of existing therapies, such as NSAIDs and opioids. Their lead therapeutic candidates are highly selective inhibitors of a voltage-gated sodium ion channel, Naᵥ1.7, which plays a critical role in the generation and conduction of pain signals.